Resource Availability
@ American Psychiatric Association. All rights reserved. This course material was originally created for SMI Adviser, and is now utilized with permission for the APAF SMI Learning Resource Center. The content in this course material is still current and relevant, yet, please be aware that some external resources and links may no longer be active or available.
Description
Large numbers of patients with serious mental illness (SMI) are not adherent to medications and treatment modalities, not only impacting their overall symptoms management but their also impairing quality of life. Less than 50% of patients with SMI continue to take their medications and adhere to their plan of care after 6 months. Non-adherence increases the risk of hospitalization, decreases recovery efforts, and extends the time in which a person will spend in inpatient facilities. It is estimated that hospitalizations due to non-adherence costs more than $100 billion a year in the United States. It is not unusual for many people with chronic SMI who do seek help to drop out from continued treatment after one or two visits. An estimated 70% of such individual stop receiving treatment due to poor interactions with their providers or lack of understanding about the need for their treatment. It is important that patients with SMI are active participants in their care with providers and the community supports in a process called shared decision making. Engaging patients in their care not only boosts adherence but also improves patients’ overall outcomes. Strategies to improve adherence to medications and treatment plans for patients with SMI will be explored in this webinar, including long-acting injectable medications (when indicated), medication strategies, and adjunctive supports.
Format
Recorded webinar, non-interactive, self-paced distance learning activity with post-test.
This presentation was recorded on July 19, 2019.
Outline
- Scope/prevalence of non-adherence to treatment
- Strategies to improve medication adherence
Learning Objectives
Identify the scope and common causes of non-adherence to recommended treatments for persons with serious mental illness (SMI) diagnoses (bipolar, schizophrenia, and treatment-resistant depression).
Identify strategies to improve adherence to medications and treatment plans for patients with SMI, including long-acting injectable medications (when indicated), medication strategies, self-management, and adjunctive supports.
Illustrate the processes by which patients with SMI might fully engage in optimal care and treatment, including supportive psychotherapy, therapeutic alliances, shared decision making, and family involvement in care.
Target Audience
Psychiatrist, Physician (non-psychiatrist), Physician Assistant, Nurse/Nurse Practitioner
Instructional Level
Introductory; Intermediate
Estimated Time to Complete
Estimated Duration: 1.0 hours
Program Start Date: December 18, 2025
Program End Date: December 18, 2028
Certificate of Participation
After completing the evaluation, participants will have the opportunity to download a certificate of participation. No continuing education credits are provided for this activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME's Standards for Integrity and Independence in Accredited Medical Education. Any individuals in a position to control the content of a CME activity - including faculty, planners, reviewers, or others - are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty
- Donna Rolin, PhD, APRN, University of Texas at Austin. Reports no financial relationships with commercial interests.
- Amber Hoberg, MSN, APRN, WellBridge Hospital. Disclosure: Speaker - Teva, Acadia, and Avanir.
Planners
- John Torous, MD, Beth Israel Deaconess Medical Center. Dr. Torous has no relevant financial relationships to disclose. (Reviewed on 6/16/22)
- Teri Brister, PhD, LPC, National Alliance on Mental Illness. Dr. Brister has no relevant financial relationships to disclose. (Reviewed on 6/23/22)
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
Internet Connection: 1 Mbps or higher
Minimum Requirements:
Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact for questions about this activity |
Contact for technical assistance